Overview
Chiyuki Kishimori practices in Tenri, Japan. Kishimori is rated as an Experienced expert by MediFind in the treatment of Waldenstrom Macroglobulinemia. Their top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL).
Their clinical research consists of co-authoring 18 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Waldenstrom Macroglobulinemia.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Large-Cell Immunoblastic Lymphoma
- Experienced
- B-Cell LymphomaKishimori isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaKishimori isExperienced. Learn about Burkitt Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Kishimori isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- LeukemiaKishimori isExperienced. Learn about Leukemia.
- Mantle Cell Lymphoma (MCL)Kishimori isExperienced. Learn about Mantle Cell Lymphoma (MCL).
- Marginal Zone Lymphoma (MZL)Kishimori isExperienced. Learn about Marginal Zone Lymphoma (MZL).